An open label, balanced, randomized clinical trial to evaluate safety & efficacy of piperine 225 mg with standard anti tubercular treatment in newly diagnosed sputum positive drug sensitive pulmonary TB adult patients in comparison with standard ..
Implementing Organization
National Institute of Tuberculosis & Respiratory Diseases, Delhi
Principal Investigator
Mr. R. Sarin
Director
|
National Institute of Tuberculosis & Respiratory Diseases, Delhi
Source
Source
Extramural R&D Projects listed in NSTMIS database 2019-20
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.